益盛药业
(002566)
| 流通市值：16.53亿 | | | 总市值：23.60亿 |
| 流通股本：2.32亿 | | | 总股本：3.31亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 853,664,904.92 | 651,148,875.84 | 469,428,507.08 | 250,973,766.69 |
| 营业收入 | 853,664,904.92 | 651,148,875.84 | 469,428,507.08 | 250,973,766.69 |
| 二、营业总成本 | 770,975,952.22 | 600,416,717.61 | 427,500,371.53 | 221,979,729.88 |
| 营业成本 | 224,202,207.43 | 178,454,833.37 | 132,054,388.45 | 70,618,510.44 |
| 税金及附加 | 17,459,310.54 | 13,728,213.05 | 9,707,414.8 | 5,106,333.16 |
| 销售费用 | 411,396,595.67 | 313,309,593.71 | 223,279,189.99 | 114,141,694.76 |
| 管理费用 | 100,134,977.62 | 79,360,629.11 | 51,451,673.44 | 26,040,189.34 |
| 研发费用 | 18,679,145.52 | 15,350,755.29 | 10,560,351.09 | 5,323,126.61 |
| 财务费用 | -896,284.56 | 212,693.08 | 447,353.76 | 749,875.57 |
| 其中:利息费用 | 13,661,640.5 | 10,231,600.1 | 6,789,223.31 | 3,616,600.99 |
| 其中:利息收入 | 14,673,375.17 | 10,114,884.95 | 6,398,327.53 | 2,959,174.19 |
| 加:公允价值变动收益 | 3,139,063.85 | 1,106,498.92 | 42,566.44 | 1,160,582.03 |
| 加:投资收益 | 1,635,792.64 | 1,871,569.75 | 1,871,569.75 | - |
| 资产处置收益 | 779,698.85 | - | - | - |
| 资产减值损失(新) | 994,121.7 | - | - | - |
| 信用减值损失(新) | 2,416,882.44 | 1,546,609.24 | 2,353,874.97 | -1,454,016.5 |
| 其他收益 | 24,075,742.84 | 17,825,547.43 | 14,555,819.55 | 11,018,913.99 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 115,730,255.02 | 73,082,383.57 | 60,751,966.26 | 39,719,516.33 |
| 加:营业外收入 | 1,383.52 | 247,233.03 | 23,352.8 | 6,786.49 |
| 减:营业外支出 | 3,969,736.63 | 3,176,543.26 | 3,126,633.95 | 3,016,014.59 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 111,761,901.91 | 70,153,073.34 | 57,648,685.11 | 36,710,288.23 |
| 减:所得税费用 | 15,651,635.5 | 9,953,953.21 | 7,683,540.83 | 5,319,141.07 |
| 六、净利润 | 96,110,266.41 | 60,199,120.13 | 49,965,144.28 | 31,391,147.16 |
| 持续经营净利润 | 96,110,266.41 | 60,199,120.13 | 49,965,144.28 | 31,391,147.16 |
| 归属于母公司股东的净利润 | 94,732,729.63 | 58,469,545.55 | 47,428,322.86 | 28,702,562.15 |
| 少数股东损益 | 1,377,536.78 | 1,729,574.58 | 2,536,821.42 | 2,688,585.01 |
| (一)基本每股收益 | 0.29 | 0.18 | 0.14 | 0.09 |
| (二)稀释每股收益 | 0.29 | 0.18 | 0.14 | 0.09 |
| 九、综合收益总额 | 96,110,266.41 | 60,199,120.13 | 49,965,144.28 | 31,391,147.16 |
| 归属于母公司股东的综合收益总额 | 94,732,729.63 | 58,469,545.55 | 47,428,322.86 | 28,702,562.15 |
| 归属于少数股东的综合收益总额 | 1,377,536.78 | 1,729,574.58 | 2,536,821.42 | 2,688,585.01 |
| 公告日期 | 2024-04-19 | 2023-10-27 | 2023-08-25 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |